US National OCS Heart Perfusion (OHP) Registry
TransMedics
100,000 participants
Aug 25, 2023
OBSERVATIONAL
Conditions
Summary
This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.
Eligibility
Inclusion Criteria1
- N/A
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The TransMedics® Organ Care System (OCS) Heart System is an FDA approved portable extracorporeal heart perfusion and monitoring system. The OCS Heart System's innovative technology was designed to comprehensively overcome the historical limitations of cold storage. The OCS Heart System expands the utilization of donor hearts by enabling the use of donor hearts deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of cold static cardioplegic preservation.
Locations(37)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05915299